Targeting SLMAP-ALK—a novel gene fusion in lung adenocarcinoma

Assessment of ALK gene rearrangements is strongly recommended by the Molecular Testing Guideline for Selection of Lung Cancer Patients proposed by IASLC, AMP, and CAP at the time of diagnosis for patients with advanced stage disease. Non-small-cell lung cancer (NSCLC) with ALK gene rearrangements or...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagan, Carlos, Barua, Subit, Hsiao, Susan J., Mansukhani, Mahesh, Saqi, Anjali, Murty, Vundavalli, Fernandes, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2019
Materias:
Rapid Cancer Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549559/
https://www.ncbi.nlm.nih.gov/pubmed/31160357
http://dx.doi.org/10.1101/mcs.a003939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549559/
https://www.ncbi.nlm.nih.gov/pubmed/31160357
http://dx.doi.org/10.1101/mcs.a003939

Ejemplares similares